Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.41 CAD | -3.21% | +2.11% | +476.19% |
May. 22 | Medicenna to Present Clinical Update on MDNA11 ABILITY-1 Trial at Sachs Oncology Innovation Forum | MT |
May. 13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MEDICENNA THERAPEUTICS CORP. | Other Biotechnology & Medical Research | -3.21% | +2.11% | +476.19% | +202.50% | +261.19% | 136M |
Technical Rankings Surperformance
- Stock Market
- Equities
- MDNA Stock
- Charts Medicenna Therapeutics Corp.
- Comparison Chart